Actuate Therapeutics ACTU
- Elraglusib Injection — Metastatic Pancreatic Ductal Adenocarcinoma Phase 2
- Elraglusib Injection — Ewing Sarcoma Phase 1
- Elraglusib Oral Tablet Preclinical
- elraglusib — Neuroblastoma Phase 1
GSK-3β (1 companies · 4 programs)
Companies with an active program directed at GSK-3β.